MS8588 is a deubiquitinase-targeting chimera (DUBTAC) against cGAS . MS8588 induces targeted stabilization of cGAS , thereby activating downstream signaling pathways. MS8588 activates the cGAS / STING / IRF3 innate immune signaling pathway. MS8588 exhibits antitumor activity.
Products | Products > Disease Areas > Cancer | Products > Disease Areas > Inflammation or Immune System Disease | Products > Signaling Pathways > PROTAC | Products > Signaling Pathways > Immunology/Inflammation | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Research Areas > Inflammation/Immunology | Products > Signaling Pathways > DUBTACs | Products > Signaling Pathways > STING | Products > Signaling Pathways > Cyclic GMP-AMP Synthase
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.